SNCA and Parkinson disease: Protein oxidation leads to structural modifications, loss of function, and aggregation of pathological proteins, such as beta-amyloid in AD and alpha-synuclein in PD, which disrupt intracellular processes and amplify neurotoxicity [79,80,81].